Where in-vivo imaging meets cytoarchitectonics: The relationship between cortical thickness and neuronal density measured with high-resolution [18F]flumazenil-PET

NeuroImage

Volumn 56, Issue 3, 2011, Pages 951-960

  La Fougère, Christian ^a,b   Grant, Sarah ^c   Kostikov, Alexey ^a   Schirrmacher, Ralf ^a   Gravel, Paul ^a   Schipper, Hyman M ^c   Reader, Andrew ^a   Evans, Alan ^a   Thiel, Alexander ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF MUNICH   (Germany)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

18F flumazenil; HRRT PET; MRI; Surface cortical thickness

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; FLUMAZENIL; FLUORINE 18;

ADULT; ARTICLE; BRAIN NERVE CELL; BRAIN SIZE; CYTOARCHITECTURE; DENDRITE; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IN VIVO STUDY; MORPHOMETRICS; NEOCORTEX; NERVE FIBER; NERVOUS SYSTEM PARAMETERS; NEURONAL DENSITY; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SURFACE CORTICAL THICKNESS; SYNAPSE;

AGED; ALGORITHMS; BRAIN MAPPING; CEREBRAL CORTEX; DATA INTERPRETATION, STATISTICAL; FEMALE; FLUMAZENIL; GABA MODULATORS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INDIVIDUALITY; ISOTOPE LABELING; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURONS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, GABA; REGRESSION ANALYSIS;

EID: 79955466690     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.11.015     Document Type: Article

References (62)

1. Ad-Dab'bagh Y., Singh V.R., Robbins S., Lerch J.P., Lyttelton O., Fombonne E., Evans A.C. Native-space cortical thickness measurments and the absence of correlation to cerebral volume. 11th Annual Meeting of the Organization for Human Brain Mapping (OHBM), Toronto 2006.
2. Amunts K., Kedo O., Kindler M., Pieperhoff P., Mohlberg H., Shah N.J., Habel U., Schneider F., Zilles K. Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: intersubject variability and probability maps. Anat Embryol (Berl) 2005, 210:343-352.
3. Amunts K., Schleicher A., Zilles K. Cytoarchitecture of the cerebral cortex-more than localization. Neuroimage 2007, 37:1061-1065. discussion 1066-1068.
4. Atack J.R., Smith A.J., Emms F., McKernan R.M. Regional differences in the inhibition of mouse in vivo [3H]Ro 15-1788 binding reflect selectivity for alpha 1 versus alpha 2 and alpha 3 subunit-containing GABAA receptors. Neuropsychopharmacology 1999, 20:255-262.
5. Beaulieu C. Numerical data on neocortical neurons in adult rat, with special reference to the GABA population. Brain Res. 1993, 609:284-292.
6. Beaulieu C., Colonnier M. Number of neurons in individual laminae of areas 3B, 4 gamma, and 6a alpha of the cat cerebral cortex: a comparison with major visual areas. J. Comp. Neurol. 1989, 279:228-234.
7. Benavides J., Peny B., Durand A., Arbilla S., Scatton B. Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system. J. Pharmacol. Exp. Ther. 1992, 263:884-896.
8. Brodmann K. Beiträge zur histologischen Lokalisation der Großhirnrinde. VI: Die Cortexgliederung des Menschen. J. Psychol. Neurol. 1908, X:231-246.
9. Collins D.L., Neelin P., Peters T.M., Evans A.C. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J. Comput. Assist. Tomogr. 1994, 18:192-205.
10. Collins C.E., Airey D.C., Young N.A., Leitch D.B., Kaas J.H. Neuron densities vary across and within cortical areas in primates. Proc. Natl Acad. Sci. USA 2010, 107:15927-15932.
11. Costes N., Dagher A., Larcher K., Evans A.C., Collins D.L., Reilhac A. Motion correction of multi-frame PET data in neuroreceptor mapping: simulation based validation. Neuroimage 2009, 47:1496-1505.
12. Delforge J., Pappata S., Millet P., Samson Y., Bendriem B., Jobert A., Crouzel C., Syrota A. Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol. J. Cereb. Blood Flow Metab. 1995, 15:284-300.
13. Economo C., Koskinas G.N. Die cytoarchitektonik der Hirnrinde des erwachsenen Menschen 1925, J. Springer, Wien und Berlin.
14. Eickhoff S.B., Paus T., Caspers S., Grosbras M.H., Evans A.C., Zilles K., Amunts K. Assignment of functional activations to probabilistic cytoarchitectonic areas revisited. Neuroimage 2007, 36:511-521.
15. Eriksson S.H., Free S.L., Thom M., Symms M.R., Martinian L., Duncan J.S., Sisodiya S.M. Quantitative grey matter histological measures do not correlate with grey matter probability values from in vivo MRI in the temporal lobe. J. Neurosci. Meth. 2009, 181:111-118.
16. Frey K.A., Holthoff V.A., Koeppe R.A., Jewett D.M., Kilbourn M.R., Kuhl D.E. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Ann. Neurol. 1991, 30:663-672.
17. Hammers A., Koepp M.J., Richardson M.P., Labbe C., Brooks D.J., Cunningham V.J., Duncan J.S. Central benzodiazepine receptors in malformations of cortical development: a quantitative study. Brain 2001, 124:1555-1565.
18. Haug H. Brain sizes, surfaces, and neuronal sizes of the cortex cerebri: a stereological investigation of man and his variability and a comparison with some mammals (primates, whales, marsupials, insectivores, and one elephant). Am. J. Anat. 1987, 180:126-142.
19. Heiss W.D., Grond M., Thiel A., Ghaemi M., Sobesky J., Rudolf J., Bauer B., Wienhard K. Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke. Stroke 1998, 29:454-461.
20. Heiss W.D., Kracht L.W., Thiel A., Grond M., Pawlik G. Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain 2001, 124:20-29.
21. Heiss W.D., Sobesky J., Smekal U., Kracht L.W., Lehnhardt F.G., Thiel A., Jacobs A.H., Lackner K. Probability of cortical infarction predicted by flumazenil binding and diffusion-weighted imaging signal intensity: a comparative positron emission tomography/magnetic resonance imaging study in early ischemic stroke. Stroke 2004, 35:1892-1898.
22. Hendry S.H., Schwark H.D., Jones E.G., Yan J. Numbers and proportions of GABA-immunoreactive neurons in different areas of monkey cerebral cortex. J. Neurosci. 1987, 7:1503-1519.
23. Hyde K.L., Lerch J.P., Zatorre R.J., Griffiths T.D., Evans A.C., Peretz I. Cortical thickness in congenital amusia: when less is better than more. J. Neurosci. 2007, 27:13028-13032.
24. Kabani N., Le Goualher G., MacDonald D., Evans A.C. Measurement of cortical thickness using an automated 3-D algorithm: a validation study. Neuroimage 2001, 13:375-380.
25. Keller S.S., Mackay C.E., Barrick T.R., Wieshmann U.C., Howard M.A., Roberts N. Voxel-based morphometric comparison of hippocampal and extrahippocampal abnormalities in patients with left and right hippocampal atrophy. Neuroimage 2002, 16:23-31.
26. Kim J.S., Singh V., Lee J.K., Lerch J., Ad-Dab'bagh Y., MacDonald D., Lee J.M., Kim S.I., Evans A.C. Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification. Neuroimage 2005, 27:210-221.
27. Koepp M.J., Labbe C., Richardson M.P., Brooks D.J., Van Paesschen W., Cunningham V.J., Duncan J.S. Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis. Brain 1997, 120(Pt 10):1865-1876.
28. Lassen N.A., Bartenstein P.A., Lammertsma A.A., Prevett M.C., Turton D.R., Luthra S.K., Osman S., Bloomfield P.M., Jones T., Patsalos P.N., et al. Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle. J. Cereb. Blood Flow Metab. 1995, 15:152-165.
29. Lerch J.P., Evans A.C. Cortical thickness analysis examined through power analysis and a population simulation. Neuroimage 2005, 24:163-173.
30. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 1996, 16:834-840.
31. Loup F., Picard F., Yonekawa Y., Wieser H.G., Fritschy J.M. Selective changes in GABAA receptor subtypes in white matter neurons of patients with focal epilepsy. Brain 2009, 132:2449-2463.
32. Lyttelton O., Boucher M., Robbins S., Evans A. An unbiased iterative group registration template for cortical surface analysis. Neuroimage 2007, 34:1535-1544.
33. MacDonald D., Kabani N., Avis D., Evans A.C. Automated 3-D extraction of inner and outer surfaces of cerebral cortex from MRI. Neuroimage 2000, 12:340-356.
34. Maguire E.A., Gadian D.G., Johnsrude I.S., Good C.D., Ashburner J., Frackowiak R.S., Frith C.D. Navigation-related structural change in the hippocampi of taxi drivers. Proc. Natl Acad. Sci. USA 2000, 97:4398-4403.
35. Massaweh G., Schirrmacher E., la Fougere C., Kovacevic M., Wangler C., Jolly D., Gravel P., Reader A.J., Thiel A., Schirrmacher R. Improved work-up procedure for the production of [(18)F]flumazenil and first results of its use with a high-resolution research tomograph in human stroke. Nucl. Med. Biol. 2009, 36:721-727.
36. Mazziotta J., Toga A., Evans A., Fox P., Lancaster J., Zilles K., Woods R., Paus T., Simpson G., Pike B., Holmes C., Collins L., Thompson P., MacDonald D., Iacoboni M., Schormann T., Amunts K., Palomero-Gallagher N., Geyer S., Parsons L., Narr K., Kabani N., Le Goualher G., Boomsma D., Cannon T., Kawashima R., Mazoyer B. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos. Trans. R. Soc. Lond. B Biol. Sci. 2001, 356:1293-1322.
37. McKernan R.M., Wafford K., Quirk K., Hadingham K.L., Harley E.A., Ragan C.I., Whiting P.J. The pharmacology of the benzodiazepine site of the GABA-A receptor is dependent on the type of gamma-subunit present. J. Recept. Signal Transduct. Res. 1995, 15:173-183.
38. Millet P., Graf C., Buck A., Walder B., Ibanez V. Evaluation of the reference tissue models for PET and SPECT benzodiazepine binding parameters. Neuroimage 2002, 17:928-942.
39. Mohler H. GABA(A) receptor diversity and pharmacology. Cell Tissue Res. 2006, 326:505-516.
40. Mueller S.G., Laxer K.D., Cashdollar N., Buckley S., Paul C., Weiner M.W. Voxel-based optimized morphometry (VBM) of gray and white matter in temporal lobe epilepsy (TLE) with and without mesial temporal sclerosis. Epilepsia 2006, 47:900-907.
41. Odano I., Halldin C., Karlsson P., Varrone A., Airaksinen A.J., Krasikova R.N., Farde L. [(18)F]Flumazenil binding to central benzodiazepine receptor studies by PET-quantitative analysis and comparisons with [(11)C]flumazenil. Neuroimage 2008, 36:958-965.
42. Olsen R.W. The GABA postsynaptic membrane receptor-ionophore complex. Site of action of convulsant and anticonvulsant drugs. Mol. Cell. Biochem. 1981, 39:261-279.
43. Petrides M., Pandya D. Comparative architectonic analysis of the human and the macaque frontal cortex. Handbook of neuropsychology 1994, 17-58. Elsevier, Amsterdam. F. Boller, J. Grafman (Eds.).
44. Petrides M., Pandya D.N. Dorsolateral prefrontal cortex: comparative cytoarchitectonic analysis in the human and the macaque brain and corticocortical connection patterns. Eur. J. Neurosci. 1999, 11:1011-1036.
45. Petrides M., Pandya D.N. Comparative cytoarchitectonic analysis of the human and the macaque ventrolateral prefrontal cortex and corticocortical connection patterns in the monkey. Eur. J. Neurosci. 2002, 16:291-310.
46. Petrides M., Pandya D. The Frontal Cortex. The Human Nervous System 2004, 950-972. Elsevier, Amsterdam. G. Paxinos, J. Mai (Eds.).
47. Richards J.G., Schoch P., Mohler H., Haefely W. Benzodiazepine receptors resolved. Experientia 1986, 42:121-126.
48. Ryzhikov N.N., Seneca N., Krasikova R.N., Gomzina N.A., Shchukin E., Fedorova O.S., Vassiliev D.A., Gulyas B., Hall H., Savic I., Halldin C. Preparation of highly specific radioactivity [18F]flumazenil and its evaluation in cynomolgus monkey by positron emission tomography. Nucl. Med. Biol. 2005, 32:109-116.
49. Salmi E., Aalto S., Hirvonen J., Langsjo J.W., Maksimow A.T., Oikonen V., Metsahonkala L., Virkkala J., Nagren K., Scheinin H. Measurement of GABA(A) receptor binding in vivo with [(11)C]Flumazenil: a test-retest study in healthy subjects. Neuroimage 2008, 41:260-269.
50. Savic I., Widen L., Thorell J.O., Blomqvist G., Ericson K., Roland P. Cortical benzodiazepine receptor binding in patients with generalized and partial epilepsy. Epilepsia 1990, 31:724-730.
51. Schleicher A., Amunts K., Geyer S., Morosan P., Zilles K. Observer-independent method for microstructural parcellation of cerebral cortex: a quantitative approach to cytoarchitectonics. Neuroimage 1999, 9:165-177.
52. Schleicher A., Morosan P., Amunts K., Zilles K. Quantitative architectural analysis: a new approach to cortical mapping. J. Autism Dev. Disord. 2009, 39:1568-1581.
53. Skoglund T.S., Pascher R., Berthold C.H. Heterogeneity in the columnar number of neurons in different neocortical areas in the rat. Neurosci. Lett. 1996, 208:97-100.
54. Sled J.G., Zijdenbos A.P., Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 1998, 17:87-97.
55. Thiel A., Reilhac A., Collins D.L., Rousset O., Neelin P., Evans A.C. Volume-of-Interest-Based Automated Partial Volume Correction for Large Numbers of PET Data Sets. Brain Imaging Using PET 2002, 129-137. Academic Press, Amsterdam. M. Senda, Y. Kimura, P. Herscovitch (Eds.).
56. Triarhou L.C. A proposed number system for the 107 cortical areas of Economo and Koskinas, and Brodmann area correlations. Stereotact. Funct. Neurosurg. 2007, 85:204-215.
57. van Velden F.H., Kloet R.W., van Berckel B.N., Wolfensberger S.P., Lammertsma A.A., Boellaard R. Comparison of 3D-OP-OSEM and 3D-FBP reconstruction algorithms for High-Resolution Research Tomograph studies: effects of randoms estimation methods. Phys. Med. Biol. 2008, 53:3217-3230.
58. van Velden F.H., Kloet R.W., van Berckel B.N., Buijs F.L., Luurtsema G., Lammertsma A.A., Boellaard R. HRRT versus HR+ human brain PET studies: an interscanner test-retest study. J. Nucl. Med. 2009, 50:693-702.
59. Wessels A.M., Simsek S., Remijnse P.L., Veltman D.J., Biessels G.J., Barkhof F., Scheltens P., Snoek F.J., Heine R.J., Rombouts S.A. Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 2006, 49:2474-2480.
60. Zezula J., Cortes R., Probst A., Palacios J.M. Benzodiazepine receptor sites in the human brain: autoradiographic mapping. Neuroscience 1988, 25:771-795.
61. Zijdenbos A.P., Dawant B.M. Brain segmentation and white matter lesion detection in MR images. Crit. Rev. Biomed. Eng. 1994, 22:401-465.
62. Zilles K. Architektonik und funktionelle Neuroanatomie der Hirnrinde des Menschen. Neurobiologie psychischer Störungen 2006, 75-140. Springer, Berlin, Heidelberg. Förstl, Hautzinger, Roth (Eds.).